The median IRS values for VRK1, YBX1, and SOX2 in grade II glioma tissues were 2, 3, and 2, respectively, whereas in grade III glioma tissues, the median IRS values were 4, 7, and 4, respectively (Figure 8A,B). This evidence concerns the gene SOX2 and central nervous system cancer.